Zoetis (ZTS) Liabilities and Shareholders Equity (2012 - 2026)

Zoetis (ZTS) reported Liabilities and Shareholders Equity of $15.2 billion for Q1 2026, up 7.49% year-over-year from $14.1 billion in Q1 2025, and down 2.17% quarter-over-quarter from $15.5 billion in Q4 2025.

Zoetis (ZTS) Liabilities and Shareholders Equity (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has 15 years of Liabilities and Shareholders Equity data on file, last reported at $15.2 billion in Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $15.2 billion, up 7.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $60.3 billion (up 6.02% YoY), and the FY2025 annual result was $15.5 billion, up 8.8% from the prior year.
  • Liabilities and Shareholders Equity eased to $15.2 billion in Q1 2026 per ZTS's latest filing, from $15.5 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $15.5 billion in Q4 2025 and troughed at $13.7 billion in Q3 2022.
  • A 5-year average of $14.3 billion and a median of $14.2 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2023 and 2025: Liabilities and Shareholders Equity decreased 4.28% in 2023, then rose 8.8% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $14.9 billion in 2022, then fell by 4.28% to $14.3 billion in 2023, then declined by 0.34% to $14.2 billion in 2024, then gained by 8.8% to $15.5 billion in 2025, then declined by 2.17% to $15.2 billion in 2026.
  • Business Quant data shows ZTS's Liabilities and Shareholders Equity at $15.2 billion in Q1 2026, $15.5 billion in Q4 2025, and $15.2 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 40.04 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 4.26 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 2.35 Bn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 2.27 Bn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 401.53 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 15.15 Bn
Dec 31, 2025 15.49 Bn
Sep 30, 2025 15.16 Bn
Jun 30, 2025 14.48 Bn
Mar 31, 2025 14.10 Bn
Dec 31, 2024 14.24 Bn
Sep 30, 2024 14.36 Bn
Jun 30, 2024 14.17 Bn
Mar 31, 2024 14.35 Bn
Dec 31, 2023 14.29 Bn
Sep 30, 2023 14.11 Bn
Jun 30, 2023 13.75 Bn
Mar 31, 2023 13.75 Bn
Dec 31, 2022 14.93 Bn
Sep 30, 2022 13.67 Bn
Jun 30, 2022 13.77 Bn
Mar 31, 2022 13.86 Bn
Dec 31, 2021 13.90 Bn
Sep 30, 2021 13.71 Bn
Jun 30, 2021 14.07 Bn